Moreover, in male rats with liver steatosis, androgens have been demonstrated to reduce the risk of a progression to non-alcoholic steatohepatitis (NASH) by downregulating the proinflammatory cytokines TNF-α and IL-6 [23]. Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.